Brigitte Smith has fifteen years experience in venture capital, business strategy and start-up company operations. Brigitte has been investing and managing investments for GBS’s $300m of life science specialised venture capital funds for the last fourteen years. GBS is Australasia’a leading life science venture capital group. The GBS team has completed more than 45 medical device and life science investments over the last fourteen years. Brigitte is on the board of GBS portfolio companies, AirXpanders Inc, Applied Physiology Pty Ltd, Kalobios Inc, Neuromonics Pty Ltd, Proacta Therapeutics Inc., and Viveve Inc.
Prior to founding GBS, Brigitte worked in the US and Australia in operating roles with early stage technology based companies, and at Bain & Company as a strategic management consultant. Ms Smith has a Bachelor of Chemical Engineering (Honours) from the University of Melbourne, and gained a Master of Business Administration (Honours) from the Harvard Business School and a Master of International Relations from the Fletcher School of Law and Diplomacy, both in Boston, USA as a Fulbright Scholar.